The detailed information for PTAB case with proceeding number IPR2017-00011 filed by Mylan Pharmaceuticals Inc. et al. against Shire Laboratory Inc . on Oct 4, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2017-00011
Filing Date
Oct 4, 2016
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Shire Laboratory Inc .
Status
Institution Denied
Respondent Application Number
11091010
Respondent Tech Center
1600
Respondent Patent Number
RE41148
Institution Decision Date
Apr 14, 2017

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Jul 6, 2017PAPERBOARD

Refund Request

Jun 29, 2017PAPERPETITIONER

Trial Instituted Document

Apr 14, 2017PAPERBOARD

Declaration of Bernhardt L. Trout, Ph.D.

Jan 17, 2017EXHIBITPATENT OWNER

Curriculum Vitae of Bernhardt L. Trout, Ph.D.

Jan 17, 2017EXHIBITPATENT OWNER

FDA Orange Book Listing for Shire¿¿¿s Adderall XR

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from File History of Burnside, U.S. Patent No. 6,322,819

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from File History of Burnside, U.S. Patent No. RE42,096

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from File History of Burnside, U.S. Patent No. 6,605,300

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from Klibanov Expert Report, IDS No. 2 (April 25, 2005), in File History of Burnside, US Patent No. RE 41,148

Jan 17, 2017EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Jan 17, 2017PAPERPATENT OWNER

FDA Approved Product Label for Shire¿¿¿s Adderall XR

Jan 17, 2017EXHIBITPATENT OWNER

Barr's Para IV Letter, IDS No. 1 (March 15, 2005)

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from Chambliss Expert Report, IDS No. 2 (Nov. 23, 2005), in File History of Burnside, US Patent No. RE 41,148

Jan 17, 2017EXHIBITPATENT OWNER

Biederman, 110 Pediatrics 258 (2002)

Jan 17, 2017EXHIBITPATENT OWNER

2016 Pelham, 34 J. Am. Acad. Child & Adolescent Psychiatry 1504 (1995)

Jan 17, 2017EXHIBITPATENT OWNER

Patrick, 12 Human Psychopharmacology 527 (1997)

Jan 17, 2017EXHIBITPATENT OWNER

FDA Approved Product Label for Shire's Adderall

Jan 17, 2017EXHIBITPATENT OWNER

Spencer, Arch Gen Psych, 2001 Aug, 58(8)-775-82

Jan 17, 2017EXHIBITPATENT OWNER

McGough, J Am Acad Child Adolesc Psychiatry 2003 Jun, 42(6)-684-91

Jan 17, 2017EXHIBITPATENT OWNER

Pliszka, Pediatric Clinics of NA, Vol.45, Issue 5, 1998 p.1085-1098

Jan 17, 2017EXHIBITPATENT OWNER

Pelham, 80 Pediatrics 491 (October 1987)

Jan 17, 2017EXHIBITPATENT OWNER

Swanson, ADHD 333 NEJM 944 (1995)

Jan 17, 2017EXHIBITPATENT OWNER

Ambrosini, 22 Current Med. Res. & Opinion 427, 428 (2006)

Jan 17, 2017EXHIBITPATENT OWNER

Swanson, 6 J. Attention Disorders (Supp.1-2002)(2002)

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from File History of Burnside, US RE 41,148

Jan 17, 2017EXHIBITPATENT OWNER

Weisler, 6 Expert Opin. in Pharmacotherapy 1003 (2005)

Jan 17, 2017EXHIBITPATENT OWNER

SUPAC-MR- Modified Release Solid Oral Dosage Forms (Sept. 1997)

Jan 17, 2017EXHIBITPATENT OWNER

Shire v. Abhai, Claim Construction Decision, DI 85

Jan 17, 2017EXHIBITPATENT OWNER

Burnside, US RE 42096

Jan 17, 2017EXHIBITPATENT OWNER

Institution Decision IPR2016-01033

Jan 17, 2017EXHIBITPATENT OWNER

Food Effect Bioavail and Fed Bioequiv Studies (2002)

Jan 17, 2017EXHIBITPATENT OWNER

Franz, Remington (Excerpt)

Jan 17, 2017EXHIBITPATENT OWNER

23 USP-NF 18 for Propranolol

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from MERCK INDEX, 11th Edition

Jan 17, 2017EXHIBITPATENT OWNER

William E. Pelham, Jr. et al., Relative Efficacy of Long-Acting Stimulants, 88 Pediatrics 226 (1990)

Jan 17, 2017EXHIBITPATENT OWNER

FDA Patent Exclusivity for Ritalin LA

Jan 17, 2017EXHIBITPATENT OWNER

Polymethacrylates, Handbook of Pharm. Excipients (1994)

Jan 17, 2017EXHIBITPATENT OWNER

Burnside, U.S. Patent No. 6,322,819

Jan 17, 2017EXHIBITPATENT OWNER

Gerald L. Brown, et. al., Clinical Pharmacology. New York: Spectrum, pp. 137-153 (1979) (¿¿¿Brown 1979b¿¿¿)

Jan 17, 2017EXHIBITPATENT OWNER

Gerald L. Brown, et al., Plasma Levels of d-Amphetamine in Hyperactive Children, 62 Psychopharmacology 133 (1979) (Brown 1979a)

Jan 17, 2017EXHIBITPATENT OWNER

Shire Motion to Amend, IPR2015-02009, Paper 14

Jan 17, 2017EXHIBITPATENT OWNER

Orange Book re Mylan ANDA 206721

Jan 17, 2017EXHIBITPATENT OWNER

Excerpts from Langer Expert Report

Jan 17, 2017EXHIBITPATENT OWNER

Adrienne Rains & Lawrence Scahill, 17 J. Child & Adolescent Psych. Nursing 177 (2004)

Jan 17, 2017EXHIBITPATENT OWNER

1964 PDR for Ritalin

Jan 17, 2017EXHIBITPATENT OWNER

Declaration of Sara E. Rosenbaum, Ph.D.

Jan 17, 2017EXHIBITPATENT OWNER

Curriculum Vitae of Sara E. Rosenbaum, Ph.D.

Jan 17, 2017EXHIBITPATENT OWNER

Shargel, Applied Bio & Pharmacokinetics (1999)

Jan 17, 2017EXHIBITPATENT OWNER

Bodmeier (1996)

Jan 17, 2017EXHIBITPATENT OWNER

Lehninger, Principles of Biochemistry, Excerpt (1993)

Jan 17, 2017EXHIBITPATENT OWNER

Gibaldi, Biopharmaceutics & Clinical Pharmacokinetics, Chapter 1 (1991)

Jan 17, 2017EXHIBITPATENT OWNER

IPR2015-02009 Decision Denying Amerigen Request for Rehearing, Paper 33

Jan 17, 2017EXHIBITPATENT OWNER

Khankari,Pharmaceutical Hydrates, Thermochimica Acta, Vol. 248, pp. 61-79 (1995)

Jan 17, 2017EXHIBITPATENT OWNER

Gibaldi, Biopharmaceutics and Clinical Pharmacokinetics, Chapter 5 (1991)

Jan 17, 2017EXHIBITPATENT OWNER

Rowland, Clinical Pharmacokinetics 2d, Ch. 4 (1989)

Jan 17, 2017EXHIBITPATENT OWNER

Winters, Basic Clinical Pharmacokinetics, Excerpt (1994)

Jan 17, 2017EXHIBITPATENT OWNER

Benet, Transplantation Proc., 31 (Suppl 3A), 75-9S (1999)

Jan 17, 2017EXHIBITPATENT OWNER

Patent Owner Mandatory Notice

Oct 24, 2016PAPERPATENT OWNER

Power of Attorney

Oct 24, 2016PAPERPATENT OWNER

Notice of Accord Filing Date

Oct 14, 2016PAPERBOARD

Petitioner's Power of Attorney

Oct 4, 2016PAPERPETITIONER

Mylan EX 1001 - Burnside U.S. Patent No. RE41,148

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1005 - U.S. Patent No. 5,837,284

Oct 4, 2016EXHIBITPETITIONER

Petition for IPR of U.S. Patent No. RE41,148

Oct 4, 2016PAPERPETITIONER

Mylan EX 1002 - Declaration of David Auslander, Ph.D.

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1003 - Auslander CV

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1004 - U.S. Patent No. 5,229,131

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1006 - PDR 28th Ed 1974

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1007 - PDR 47th Ed 1993

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1008 - PDR 49th Ed 1995

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1012 - Chiao 19th Ed 1995

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1013 - Hartung & Munch 1931

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1014 - Hoffman 9th Ed 1996

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1016 - Porter 29th Ed 1995

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1009 - PDR 51st Ed 1997

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1010 - ANSEL, POPOVICH & ALLEN 6th ed. 1995

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1011 - Brown 1980

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1015 - Merck Index 11 Ed 1989

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1020 - PO Prelim Resp 01/19/16

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1021 - Petition for IPR RE42096

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1022 - Decision Instituting IPR RE42096

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1025 - Select Portion of NDA 11522

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1027 - PDR 48th Ed 1994

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1033 - Office Action - US App No 09/807,462

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1034 - App Remarks US App No 09/807,462

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1017 - Sonsalia 19th Ed 1995

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1018 - Stempel 7th Ed 1971

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1019 - US Pharmacopeia 1994

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1023 - U.S. Patent 4,927,640

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1024 - U.S. Patent 5,783,215

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1026 - Medical Letters

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1028 - Records from PDR51 ed 1997

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1029 - Declaration of Palmieri, Ph.D.

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1030 - CV of Anthony Palmieri

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1031 - Slattum 1996

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1032 - Benet 1995

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1035 - App Arguments US App 09/807462

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1036 - App Arguments 06/10/2003 US App 09/807462

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1037 - Angrist Vol 22 1987

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1038 - Hinsvark 1973

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1039 - Birmaher 1989

Oct 4, 2016EXHIBITPETITIONER

Mylan EX 1040 - Specs and Test Methods 07/1999

Oct 4, 2016EXHIBITPETITIONER